TSX:BHC • CA0717341071
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BAUSCH HEALTH COS INC (BHC.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-27 | TD Cowen | Maintains | Hold -> Hold |
| 2023-12-21 | Truist Securities | Maintains | Hold -> Hold |
| 2022-08-10 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-08-08 | Guggenheim Securities | Upgrade | |
| 2022-07-26 | RBC Royalbank | Downgrade | Outperform |
| 2022-05-09 | RBC Royalbank | Downgrade | Outperform |
| 2022-05-05 | Morningstar | Initiate | Buy |
| 2022-02-25 | RBC Royalbank | Downgrade | Outperform |
| 2022-02-01 | RBC Capital | Downgrade | Outperform |
| 2021-05-05 | RBC Capital | Downgrade | Outperform |
| 2021-04-30 | RBC Capital | Maintains | Outperform |
| 2021-02-25 | Barclays | Upgrade | Overweight |
| 2021-02-18 | RBC Capital | Upgrade |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.757B 7.79% | 9.625B 9.91% | 10.266B 6.66% | 10.739B 4.61% | 10.728B -0.10% | 9.628B -10.25% | 9.806B 1.85% | 9.875B 0.70% | 9.867B -0.08% | 10.161B 2.98% | |
| EBITDA YoY % growth | 2.863B 2.84% | 3.121B 9.01% | 3.393B 8.72% | 3.835B 13.03% | 3.769B -1.72% | 2.687B -28.71% | 3.013B 12.13% | 3.046B 1.10% | 3.109B 2.07% | N/A | |
| EBIT YoY % growth | 1.599B 15.04% | 1.854B 15.95% | 2.185B 17.85% | 3.519B 61.05% | 3.323B -5.57% | 2.815B -15.29% | 2.943B 4.55% | 2.985B 1.43% | 2.992B 0.23% | 3.158B 5.55% | |
| Operating Margin | 18.26% | 19.26% | 21.28% | 32.77% | 30.98% | 29.24% | 30.01% | 30.23% | 30.32% | 31.08% | |
| EPS YoY % growth | 3.51 13.96% | 3.77 7.41% | 3.77 | 4.59 21.76% | 4.32 -6.00% | 3.21 -25.69% | 3.25 1.21% | 3.58 10.27% | 3.80 6.26% | 4.19 10.23% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.07 17.09% | 1.37 18.20% | 1.45 31.99% | 0.72 -8.06% | 0.98 -7.58% | 1.15 -16.39% | 1.30 -10.61% |
| Revenue Q2Q % growth | 2.657B 5.02% | 2.782B 3.77% | 2.882B 3.08% | 2.449B -2.97% | 2.677B 0.75% | 2.778B -0.14% | 2.914B 1.11% |
| EBITDA Q2Q % growth | 924.15M -13.55% | 1.069B -34.62% | 1.082B -43.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 895.87M 96.03% | 1.097B 53.00% | 1.1B 52.99% | N/A | N/A | N/A | N/A |
All data in USD
9 analysts have analysed BHC.CA and the average price target is 10.2 CAD. This implies a price increase of 32.99% is expected in the next year compared to the current price of 7.67.
BAUSCH HEALTH COS INC (BHC.CA) will report earnings on 2026-07-28.
The consensus EPS estimate for the next earnings of BAUSCH HEALTH COS INC (BHC.CA) is 1.07 CAD and the consensus revenue estimate is 2.66B CAD.
The expected long term growth rate for BAUSCH HEALTH COS INC (BHC.CA) is -2.16%.